Year: 2003 Source: CNS Drugs, v.17, no.4, (2003), p.273-280 SIEC No: 20031019

The focus of this profile is the use of clozapine in the prevention of suicide in patients with schizophrenia or schizoaffective disorder. The authors examine the drug’s pharmacodynamic profile, its pharmacokinetic profile, recent findings from therapeutic trials, its tolerability, its dosage & administration, & its current status. (43 refs)